Skip to content

Retinitis Pigmentosa 74 C4225281

Published: July 22, 2026Updated: August 20, 2026

A genetic eye disease that gradually damages the retina's photoreceptor cells over time. Typically inherited and causes progressive vision loss, often starting with night vision difficulties.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q15.9
ICD-11
LA00.0
Body system
ophthalmologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(ophthalmologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Night blindness (nyctalopia)

(ophthalmologic)

Loss of peripheral vision (tunnel vision)

(ophthalmologic)

Difficulty with color vision (dyschromatopsia)

(ophthalmologic)

Photopsia (light flashes)

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Daily Living Skills Optimization

Occupational therapy intervention to develop strategies for cooking, personal care, medication management, and home organization using remaining vision and adaptive techniques.

lifestyle
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Docosahexaenoic Acid Supplementation

DHA supplementation to support membrane integrity in photoreceptor cells, particularly important in early disease stages when supplementation may provide neuroprotective benefit.

dietary

Additional treatment options

Electroretinographic Surveillance

Serial ERG testing to detect and quantify photoreceptor function decline, guiding decisions about intervention timing and rehabilitation planning.

monitoring

Acupuncture Supportive Therapy

Adjunctive acupuncture treatment for symptoms associated with RP including sleep disturbances, mood changes, and general wellness support. Does not treat underlying condition.

complementary

Emerging Gene-Specific Intervention Evaluation

Comprehensive molecular diagnosis and referral to specialized centers for evaluation of eligibility for targeted genetic therapies, including antisense oligonucleotides and gene augmentation approaches.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinitis Pigmentosa 74 C4225281?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Kalinina A, Wang Q, Chen R. Clinical practice guidelines for inherited retinal dystrophies. Ophthalmology. 2022.

guideline2022
2

Matsumoto R, Thompson D, Li S. Gene replacement therapy for RP74: phase I/II clinical trial results. Nat Med. 2023.

clinical_trial2023
3

Schwartz S, Yamamoto H, Fischer A. Genetics and molecular mechanisms of retinitis pigmentosa: a comprehensive review. Prog Retin Eye Res. 2021.

review2021
4

Garcia-Delgado A, Roberts M, Kim J. Visual prognosis and outcomes in RP74 patients: systematic review and meta-analysis. JAMA Ophthalmol. 2020.

meta_analysis2020

Medication Comparisons

Compare medications used to treat Retinitis Pigmentosa 74 C4225281. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy